您的购物车当前为空
DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation,non-steroidal anti-inflammatory effects,and glucose lowering effects)without the undesired PPARγ-related weight gain side effect.
别名 DRX065, DRX 065, deuterated R-enantiomer of pioglitazone
DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation,non-steroidal anti-inflammatory effects,and glucose lowering effects)without the undesired PPARγ-related weight gain side effect.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 4,880 | 10-14周 | |
| 5 mg | ¥ 9,870 | 10-14周 | |
| 10 mg | ¥ 13,900 | 10-14周 | |
| 25 mg | ¥ 19,800 | 10-14周 | |
| 50 mg | ¥ 27,900 | 10-14周 | |
| 100 mg | ¥ 37,600 | 10-14周 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
凭借在化合物合成方面的丰富经验,我们可以根据您的研究需求为该产品提供快速定制合成服务。
| 产品描述 | DRX-065 is a stabilized and deuterated R-enantiomer of pioglitazone. DRX-065 has pharmacological properties desirable for the treatment of NASH (mitochondrial function modulation, non-steroidal anti-inflammatory effects, and glucose lowering effects) without the undesired PPARγ-related weight gain side effect. |
| 别名 | DRX065, DRX 065, deuterated R-enantiomer of pioglitazone |
| 分子量 | 357.45 |
| 分子式 | C19H20N2O3S |
| CAS No. | 1259828-75-5 |
| Smiles | C([C@@]1(C(=O)NC(=O)S1)[2H])C2=CC=C(OCCC3=CC=C(CC)C=N3)C=C2 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多